ELISA Kit for Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)

PK1; EGVEGF; PRK1, PROK1; Prokineticin 1; Black Mamba Toxin-Related Protein; Mambakine

FOR IN VITRO AND RESEARCH USE ONLY, NOT FOR USE IN CLINICAL DIAGNOSTIC PROCEDURES!
  • ELISA Kit for Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)Packages (Simulation)
  • ELISA Kit for Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)Packages (Simulation)
  • ELISA Kit for Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)Results demonstration
  • SEA024Hu.jpgTypical Standard Curve
  • CertificateISO9001: 2008, ISO13485: 2003 Registered

Specificity

This assay has high sensitivity and excellent specificity for detection of Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF).
No significant cross-reactivity or interference between Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) and analogues was observed.

Recovery

Matrices listed below were spiked with certain level of recombinant Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) and the recovery rates were calculated by comparing the measured value to the expected amount of Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) in samples.

MatrixRecovery range (%)Average(%)
serum(n=5)84-9389
EDTA plasma(n=5)80-10187
heparin plasma(n=5)90-10498

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample1:21:41:81:16
serum(n=5)95-102%83-96%82-96%80-103%
EDTA plasma(n=5)85-92%92-99%78-104%95-105%
heparin plasma(n=5)84-105%94-102%80-98%98-105%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

ReagentsQuantityReagentsQuantity
Pre-coated, ready to use 96-well strip plate1Plate sealer for 96 wells4
Standard2Standard Diluent1×20mL
Detection Reagent A1×120µLAssay Diluent A1×12mL
Detection Reagent B1×120µLAssay Diluent B1×12mL
TMB Substrate1×9mLStop Solution1×6mL
Wash Buffer (30 × concentrate)1×20mLInstruction manual1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 3 times;
5. Add 100µL prepared Detection Reagent B. Incubate 30 minutes at 37°C;
6. Aspirate and wash 5 times;
7. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
8. Add 50µL Stop Solution. Read at 450nm immediately.

ELISA Kit for Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)

Test principle

The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF). Standards or samples are then added to the appropriate microtiter plate wells with a biotin-conjugated antibody specific to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF). Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF), biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Related products

Catalog No.Organism species: Homo sapiens (Human)Applications
RPA024Hu01Recombinant Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)Positive Control; Immunogen; SDS-PAGE; WB.
APA024Hu01Active Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)Cell culture; Activity Assays.
PAA024Hu01Polyclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)WB; IHC; ICC; IP.
MAA024Hu22Monoclonal Antibody to Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)WB; IHC; ICC; IP.
SEA024HuELISA Kit for Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)Enzyme-linked immunosorbent assay for Antigen Detection.
SCA024HuCLIA Kit for Endocrine Gland Derived Vascular Endothelial Growth Factor (EG-VEGF)Chemiluminescent immunoassay for Antigen Detection.
GUESTBOOK